Thymic Export Function and T Cell Homeostasis in Patients with Relapsing Remitting Multiple Sclerosis

The Journal of Immunology ◽

10.4049/jimmunol.171.1.432 ◽

2003 ◽

Vol 171 (1) ◽

pp. 432-437 ◽

Author(s):

Andreas Hug ◽

Mirjam Korporal ◽

Isabella Schröder ◽

Jürgen Haas ◽

Katharina Glatz ◽

...

Keyword(s):

Multiple Sclerosis ◽

T Cell ◽

T Cell Homeostasis ◽

Cell Homeostasis ◽

Relapsing Remitting ◽

Remitting Multiple Sclerosis ◽

Relapsing Remitting Multiple Sclerosis

Download Full-text

Altered naive CD4 and CD8 T cell homeostasis in patients with relapsing-remitting multiple sclerosis: thymic versus peripheral (non-thymic) mechanisms

Clinical & Experimental Immunology ◽

10.1111/j.1365-2249.2005.02990.x ◽

2006 ◽

Vol 143 (2) ◽

pp. 305-313 ◽

Author(s):

D. A. Duszczyszyn ◽

J. D. Beck ◽

J. Antel ◽

A. Bar-Or ◽

Y. Lapierre ◽

...

Keyword(s):

Multiple Sclerosis ◽

T Cell ◽

T Cell Homeostasis ◽

Cell Homeostasis ◽

Relapsing Remitting ◽

Remitting Multiple Sclerosis ◽

Relapsing Remitting Multiple Sclerosis

Download Full-text

Long-Term Lymphocyte Counts in Patients with Relapsing-Remitting Multiple Sclerosis (RRMS) Treated with Cladribine Tablets 3.5 mg/kg: Total Lymphocytes, B and T Cell Subsets

10.26226/morressier.59a3eda8d462b8028d8950f6 ◽

2017 ◽

Author(s):

Per Soelberg-Sorensen

Keyword(s):

Multiple Sclerosis ◽

T Cell ◽

T Cell Subsets ◽

Relapsing Remitting ◽

Remitting Multiple Sclerosis ◽

Relapsing Remitting Multiple Sclerosis

Download Full-text

Cytotoxic CD4+CD28null T cell expansions are associated with worse disease progression in patients with relapsing remitting multiple sclerosis

10.26226/morressier.59a3eda2d462b8028d8949af ◽

2017 ◽

Author(s):

Liesbet M. Peeters

Keyword(s):

Multiple Sclerosis ◽

T Cell ◽

Disease Progression ◽

Relapsing Remitting ◽

Remitting Multiple Sclerosis ◽

Relapsing Remitting Multiple Sclerosis

Download Full-text

Faculty Opinions recommendation of In active relapsing-remitting multiple sclerosis, effector T cell resistance to adaptive T(regs) involves IL-6-mediated signaling.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.717991564.793473379 ◽

2013 ◽

Author(s):

Mark Atkinson ◽

Todd Brusko

Keyword(s):

Multiple Sclerosis ◽

T Cell ◽

Cell Resistance ◽

Effector T Cell ◽

Relapsing Remitting ◽

Remitting Multiple Sclerosis ◽

Relapsing Remitting Multiple Sclerosis

Download Full-text

Impact of fingolimod on CD4+ T cell subset and cytokine profile of relapsing remitting multiple sclerosis patients

Journal of Neuroimmunology ◽

10.1016/j.jneuroim.2019.577065 ◽

2019 ◽

Vol 337 ◽

pp. 577065 ◽

Author(s):

Murat Kürtüncü ◽

Vuslat Yılmaz ◽

Halil İbrahim Akçay ◽

Recai Türkoğlu ◽

Burcu Altunrende ◽

...

Keyword(s):

Multiple Sclerosis ◽

T Cell ◽

Cell Subset ◽

Cytokine Profile ◽

T Cell Subset ◽

Relapsing Remitting ◽

Remitting Multiple Sclerosis ◽

Multiple Sclerosis Patients ◽

Relapsing Remitting Multiple Sclerosis

Download Full-text

Secondary progressive in contrast to relapsing-remitting multiple sclerosis patients show a normal CD4+CD25+regulatory T-cell function and FOXP3 expression

Journal of Neuroscience Research ◽

10.1002/jnr.20852 ◽

2006 ◽

Vol 83 (8) ◽

pp. 1432-1446 ◽

Author(s):

Koen Venken ◽

Niels Hellings ◽

Karen Hensen ◽

Jean-Luc Rummens ◽

Robert Medaer ◽

...

Keyword(s):

Multiple Sclerosis ◽

T Cell ◽

Regulatory T Cell ◽

Cell Function ◽

Foxp3 Expression ◽

Secondary Progressive ◽

Relapsing Remitting ◽

Remitting Multiple Sclerosis ◽

Multiple Sclerosis Patients ◽

Relapsing Remitting Multiple Sclerosis

Download Full-text

T cell response to myelin basic protein and CNS inflammatory activity during the course of relapsing-remitting multiple sclerosis

Journal of Neuroimmunology ◽

10.1016/s0165-5728(98)91649-6 ◽

1998 ◽

Vol 90 (1) ◽

pp. 79

Author(s):

M. Vergelli ◽

B. Mazzanti ◽

E. Traggiai ◽

A. Parigi ◽

L. Massacesi

Keyword(s):

Multiple Sclerosis ◽

T Cell ◽

Myelin Basic Protein ◽

Cell Response ◽

Basic Protein ◽

T Cell Response ◽

Inflammatory Activity ◽

Relapsing Remitting ◽

Remitting Multiple Sclerosis ◽

Relapsing Remitting Multiple Sclerosis

Download Full-text

Differential Reconstitution of T Cell Subsets following Immunodepleting Treatment with Alemtuzumab (Anti-CD52 Monoclonal Antibody) in Patients with Relapsing–Remitting Multiple Sclerosis

The Journal of Immunology ◽

10.4049/jimmunol.1301926 ◽

2013 ◽

Vol 191 (12) ◽

pp. 5867-5874 ◽

Author(s):

Xin Zhang ◽

Yazhong Tao ◽

Manisha Chopra ◽

Mihye Ahn ◽

Karen L. Marcus ◽

...

Keyword(s):

Multiple Sclerosis ◽

Monoclonal Antibody ◽

T Cell ◽

T Cell Subsets ◽

Relapsing Remitting ◽

Remitting Multiple Sclerosis ◽

Relapsing Remitting Multiple Sclerosis

Download Full-text

Identification of CD4+ T cell biomarkers for predicting the response of patients with relapsing‑remitting multiple sclerosis to natalizumab treatment

Molecular Medicine Reports ◽

10.3892/mmr.2019.10283 ◽

2019 ◽

Author(s):

Paolo Fagone ◽

Emanuela Mazzon ◽

Santa Mammana ◽

Roberto Di Marco ◽

Flaminia Spinasanta ◽

...

Keyword(s):

Multiple Sclerosis ◽

T Cell ◽

Relapsing Remitting ◽

Natalizumab Treatment ◽

Remitting Multiple Sclerosis ◽

Relapsing Remitting Multiple Sclerosis

Download Full-text

T cell receptor β chain genotyping in Australian relapsing-remitting multiple sclerosis patients

Multiple Sclerosis Journal ◽

10.1191/135245800701565990 ◽

2000 ◽

Vol 6 (3) ◽

pp. 140-147 ◽

Author(s):

M.M.c.W. Buhler ◽

B.H. Bennetts ◽

R.N.S. Heard ◽

G.J. Stewart

Keyword(s):

Multiple Sclerosis ◽

T Cell ◽

T Cell Receptor ◽

Cell Receptor ◽

Relapsing Remitting ◽

Remitting Multiple Sclerosis ◽

Multiple Sclerosis Patients ◽

Relapsing Remitting Multiple Sclerosis ◽

Download Full-text